Cargando…

Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant

PURPOSE: We provide evidence for the reclassification of the BRCA1:c.5017_5019del variant by presenting the clinicopathological characteristics, clinical outcomes, and family history of breast or ovarian cancer in 17 patients with this variant. METHODS: This study included breast or ovarian cancer p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bang, Yoon Ju, Kwon, Won Kyung, Kim, Jong-Won, Lee, Jeong Eon, Jung, Boo Yeon, Kim, Mina, Kim, Jisun, An, Jeongshin, Jung, Seung Pil, Kim, Hong-Kyu, Kim, Zisun, Youn, Hyun Jo, Ryu, Jai Min, Kim, Sung-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763777/ https://www.ncbi.nlm.nih.gov/pubmed/36601340 http://dx.doi.org/10.4174/astr.2022.103.6.323

Ejemplares similares

Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
por: Lee, Young-Jae, et al.
Publicado: (2017)

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant
por: Park, Hyung Seok, et al.
Publicado: (2020)

Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation
por: Kim, Ju Won, et al.
Publicado: (2023)

Performance evaluation of an amplicon‐based next‐generation sequencing panel for BRCA1 and BRCA2 variant detection
por: Park, Kuenyoul, et al.
Publicado: (2020)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2020)

Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry
por: Kang, Sang Yull, et al.
Publicado: (2018)

Erratum: Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry
por: Kang, Sang Yull, et al.
Publicado: (2019)

Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
por: Choi, Min Chul, et al.
Publicado: (2018)

Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea
por: Hong, Joohyun, et al.
Publicado: (2021)

Clinicopathological characteristics of BRCA-associated breast cancer in Asian patients
por: Kim, Eun-Kyu, et al.
Publicado: (2020)

The reality in the follow-up of breast cancer survivors: survey of Korean Breast Cancer Society
por: Kim, Ku Sang, et al.
Publicado: (2015)

Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
por: Choi, Min Chul, et al.
Publicado: (2018)

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2020)

Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns: A Long-Term Follow-Up Study of Koreans
por: Kim, Hakyoung, et al.
Publicado: (2020)

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
por: Kim, Hakyoung, et al.
Publicado: (2019)

Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer
por: Kim, Haeyoung, et al.
Publicado: (2016)

NAP Family CG5017 Chaperone Pleiotropically Regulates Human AHR Target Genes Expression in Drosophila Testis
por: Akishina, Angelina A., et al.
Publicado: (2018)

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2
por: Eoh, Kyung Jin, et al.
Publicado: (2018)

Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1
por: Jeon, Ye Won, et al.
Publicado: (2015)

Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
por: Kim, Jinyong, et al.
Publicado: (2023)

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2021)

Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
por: Kim, Hee Nam, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
por: Jang, Jaehyeok, et al.
Publicado: (2023)

A Review of Breast Cancer Survivorship Issues from Survivors' Perspectives
por: Cho, Jihyoung, et al.
Publicado: (2014)

Improved Detection of Germline Mutations in Korean VHL Patients by Multiple Ligation-dependent Probe Amplification Analysis
por: Cho, Hyun-Jung, et al.
Publicado: (2009)

Comment on “Subcutaneous fat area at the upper thigh level is a useful prognostic marker in the elderly with femur fracture” by Kim et al.
por: Kim, Youn‐Jung, et al.
Publicado: (2022)

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
por: Woo, Jinsun, et al.
Publicado: (2021)

The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database
por: Min, Sun Young, et al.
Publicado: (2016)

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study
por: Son, Byung Ho, et al.
Publicado: (2012)

Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients
por: Kim, Jee Ah, et al.
Publicado: (2020)

Unmet needs and quality of life of caregivers of Korean breast cancer survivors: a cross-sectional study
por: Lee, Jong Won, et al.
Publicado: (2021)

Novel Germline Mutation of BRCA1 Gene in a 56-Year-Old Woman with Breast Cancer, Ovarian Cancer, and Diffuse Large B-Cell Lymphoma
por: Kim, Hye Sook, et al.
Publicado: (2015)

Breast Cancer Statistics in Korea, 2018
por: Kang, Sang Yull, et al.
Publicado: (2021)

Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test
por: Kim, Yoo-Na, et al.
Publicado: (2022)

Bilateral adrenal pheochromocytoma with a germline L790F mutation in the RET oncogene
por: Min, Jun Won, et al.
Publicado: (2012)

Trends and Outcomes of Non-compliance with Treatment for Gastric Cancer in Korea over the 16 years from 1999 to 2015
por: Eom, Bang Wool, et al.
Publicado: (2019)

Associations of Circulating Levels of Trimethylamine N-oxide, Choline, Carnitine, and Betaine with Inflammatory Markers Among Breast Cancer Survivors
por: Lee, Yeon Jin, et al.
Publicado: (2022)

Primary breast lymphoma: a single institution's experience
por: Jung, Seung Pil, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c1mso41p9defiutr7ahbapdplq